Table 6. Absolute numbers of CEC expressing activation-related adhesion and procoagulant molecules.
| Groups | CD54+ CEC/ml | P* | CD62E+ CEC/ml | P* | CD142+ CEC/ml | P* |
| Control | 72 (0–227) | NA | 145 (0–604) | NA | 77 (0–366) | NA |
| VTE | 238 (29–1179) | <0.001 | 683 (205–2990) | <0.001 | 309 (93–2532) | <0.001 |
| MPN | 140 (0–521) | NS | 677 (200–2390) | <0.001 | 0 (0–1154) | NS |
| MPN (ET) | 140 (0–493) | NS | 696 (200–1941) | <0.001 | 0 (0–618) | NS |
| MPN (PV) | 124 (0–521) | NS | 602 (359–2390) | <0.001 | 47 (0–1154) | NS |
Abbreviations: CEC, circulating endothelial cells; MPN, myeloproliferative neoplasms; VTE, venous thromboembolism; ET, essential thrombocythaemia, PV, polycythaemia vera; NA, not applicable; NS, not statistically significant.
Results are presented as median (minimum – maximum) values.
*
Patients versus controls; Mann-Whitney test; p<0.05 was considered statistically significant.